Effects of a combined oral contraceptive containing 20 mcg of ethinylestradiol and 3 mg of drospirenone on the blood pressure, renin-angiotensin-aldosterone system, insulin resistance, and androgenic profile of healthy young women

References

• Mishell Jr DR. State of the art in hormonal contraception: an overview. Am J Obstet Gynecol 2004;190:S1–4
   PubMed Web of Science ®Google Scholar
• Sitruk-Ware R, Nath A. Metabolic effects of contraceptive steroids. Rev Endocr Metab Disord 2011;12:63–75
   PubMed Web of Science ®Google Scholar
• Sitruk-Ware R. New progestagens for contraceptive use. Hum Reprod Update 2006;12:169–78
   PubMed Web of Science ®Google Scholar
• Nath A, Sitruk-Ware R. Different cardiovascular effects of progestins according to structure and activity. Climacteric 2009;12:96–101
   PubMed Web of Science ®Google Scholar
• Godsland IF, Walton C, Felton C, et al. Insulin resistance, secretion, and metabolism in users of oral contraceptives. J Clin Endocrinol Metab 1992;74:64–70
   PubMed Web of Science ®Google Scholar
• Kojima T, Lindheim SR, Duffy DM, et al. Insulin sensitivity is decreased in normal women by doses of ethinyl estradiol used in oral contraceptives. Am J Obstet Gynecol 1993;169:1540–4
   PubMed Web of Science ®Google Scholar
• Weir RJ. When the pill causes a rise in blood pressure. Drugs 1978;16:522–7
   PubMed Web of Science ®Google Scholar
• Crane MG, Harris JJ. Estrogens and hypertension: effect of discontinuing estrogens on blood pressure, exchangeable sodium and the renin-aldosterone system. Am J Med Sci 1978;276:33–55
   PubMed Web of Science ®Google Scholar
• The WHO multicentre trial of the vasopressor effects of combined oral contraceptives: 1. Comparisons with IUDs. Contraception 1989;40:129–45. 33
   PubMedGoogle Scholar
• The WHO multicentre trial of the vasopressor effects of combined oral contraceptives: 2. Lack of effect of estrogen. Contraception 1989;40:147–56. 34
   PubMedGoogle Scholar
• Chasan-Taber L, Walter CW, JoAnn EM, et al. Prospective study of oral contraceptives and hypertension among women in the United States. Circulation 1996;94:483–9
   PubMed Web of Science ®Google Scholar
• Oelkers W, Schoneshofer M, Blumel A. Effects of progesterone and four synthetic progestogens on sodium balance and the renin-aldosterone system in man. J Clin Endocrinol Metab 1974;39:882–90
   PubMed Web of Science ®Google Scholar
• Oelkers WK. Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure. Steroids 1996;61:166–71
   PubMed Web of Science ®Google Scholar
• Oelkers W. Antimineralocorticoid activity of a novel oral contraceptive containing drospirenone, a unique progestogen resembling natural progesterone. Eur J Contracept Reprod Health Care 2002;7:19–26
   PubMed Web of Science ®Google Scholar
• Oelkers W, Berger V, Bolik A, et al. Dihydrospirorenone, a new progestogen with antimineralocorticoid activity: effects on ovulation, electrolyte excretion, and the renin-aldosterone system in normal women. J Clin Endocrinol Metab 1991;73:837–42
   PubMed Web of Science ®Google Scholar
• Oelkers W, Helmerhorst FM, Wuttke W, Heithecker R. Effect of an oral contraceptive containing drospirenone on the renin-angiotensin-aldosterone system in healthy female volunteers. Gynecol Endocrinol 2000;14:476–8
   PubMedGoogle Scholar
• Oelkers W, Foidart JM, Dombrovicz N, et al. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism. J Clin Endocrinol Metab 1995;80:1816–21
   PubMed Web of Science ®Google Scholar
• World Health Organization. Medical eligibility criteria for contraceptive use. 4th ed. Amsterdam: Elsevier; 2010
   Google Scholar
• Pickering TG, Hall JE, Appel LJ, et al. AHA Scientific Statement. Recommendations for blood pressure measurement in humans and experimental animals. Part 1: blood pressure measurement in humans: a statement for professionals from the subcommittee of professional and public education of the American heart association council on high blood pressure research. Hypertension 2005;45:142–61
   PubMed Web of Science ®Google Scholar
• Sealey JE. Plasma renin activity and plasma prorenin assays. Clin Chem 1991;37:1811–19
   PubMed Web of Science ®Google Scholar
• Giribela CR, Melo NR, Silva RC, et al. A combined oral contraceptive containing drospirenone changes neither endothelial function nor hemodynamic parameters in healthy young women: a prospective clinical trial. Contraception 2012;86:35–41
   PubMed Web of Science ®Google Scholar
• Nisenbaum MG, de Melo NR, Giribela CR, et al. Effects of a contraceptive containing drospirenone and ethinyl estradiol on blood pressure and autonomic tone: a prospective controlled clinical trial. Eur J Obstet Gynecol Reprod Biol 2014;175:62–6
   PubMed Web of Science ®Google Scholar
• Klipping C, Marr J. Effects of two combined oral contraceptives containing ethinyl estradiol 20 microg combined with either drospirenone or desogestrel on lipids, hemostatic parameters and carbohydrate metabolism. Contraception 2005;71:409–16
   PubMed Web of Science ®Google Scholar
• Taneepanichskul S, Phupong V. Influence of a new oral contraceptive with drospirenone on lipid metabolism. Gynecol Endocrinol 2007;23:347–50
   PubMed Web of Science ®Google Scholar
• Gaspard U, Endrikat J, Desager JP, et al. A randomized study on the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on lipid and lipoprotein metabolism over a period of 13 cycles. Contraception 2004;69:271–8
   PubMed Web of Science ®Google Scholar
• Cagnacci A, Piacenti I, Zanin R, et al. Influence of an oral contraceptive containing drospirenone on insulin sensitivity of healthy women. Eur J Obstet Gynecol Reprod Biol 2014;178:48–50
   PubMed Web of Science ®Google Scholar
• Oelkers W, Foidart JM, Dombrovicz N, et al. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism. J Clin Endocrinol Metab 1995;80:18:16–21
   Google Scholar
• Cagnacci A, Ferrari S, Tirelli A, et al. Insulin sensitivity and lipid metabolism with oral contraceptives containing chlormadinone acetate or desogestrel: a randomized trial. Contraception 2009;79:111–16
   PubMed Web of Science ®Google Scholar
• Knopp RH, Broyles FE, Cheung M, et al. Comparison of the lipoprotein, carbohydrate, and hemostatic effects of phasic oral contraceptives containing desogestrel or levonorgestrel. Contraception 2001;63:1–11
   PubMed Web of Science ®Google Scholar
• Song S, Chen JK, Yang PJ, et al. A cross-over study of three oral contraceptives containing ethinyloestradiol and either desogestrel or levonorgestrel. Contraception 1992;45:523–32
   PubMed Web of Science ®Google Scholar